Practice variations in voice treatment selection following vocal fold mucosal resection.

ABSTRACT:

Objectives/hypothesis

To characterize initial voice treatment selection following vocal fold mucosal resection in a Medicare population.

Study design

Retrospective analysis of a large, nationally representative Medicare claims database.

Methods

Patients with > 12 months of continuous Medicare coverage who underwent a leukoplakia- or cancer-related vocal fold mucosal resection (index) procedure during calendar years 2004 to 2009 were studied. The primary outcome of interest was receipt of initial voice treatment (thyroplasty, vocal fold injection, or speech therapy) following the index procedure. We evaluated the cumulative incidence of each postindex treatment type, treating the other treatment types as competing risks, and further evaluated postindex treatment utiliz

SUBMITTER: Moore JE 

PROVIDER: S-EPMC5018919 | biostudies-literature | 2016 Nov

REPOSITORIES: biostudies-literature